Sponsors (8)
The bill channels sustained funding and DOJ support to strengthen law-enforcement responses to fentanyl trafficking and improve data-driven targeting, but it increases federal spending and carries risks of local resource diversion, prosecutorial disruption, and civil-liberties concerns if safeguards and offsets are not put in place.
Federal, State, local, and Tribal law enforcement agencies will receive sustained funding and operational assistance to investigate and interdict fentanyl, increasing seizures and disruption of trafficking networks.
Provides $333 million annually (FY2025–2030) to the High Intensity Drug Trafficking Areas (HIDTA) program, enabling continued regional drug-threat response, staffing, and programs.
Requires annual HIDTA reports and threat-assessment data, improving transparency and enabling more targeted, data-driven responses to fentanyl trafficking patterns and routes.
The $333 million annual authorization increases federal spending and could raise concerns about opportunity costs or higher deficits if not offset.
Expanded law enforcement focus and reallocated resources toward fentanyl may divert attention and funding from other local public-safety priorities.
Temporary reassignment of Assistant U.S. Attorneys could disrupt local federal docket management and delay prosecutions in other cases where those AUSAs previously served.
Based on analysis of 2 sections of legislative text.
Adds fentanyl-focused HIDTA reporting and assessments, expands HIDTA purposes for fentanyl interdiction, authorizes $333M/year for FY2025–2030, and requires DOJ to provide prosecutorial support including AUSA reassignments.
Official title: Amend the Office of National Drug Control Prevention Act of 1998 to include new requirements for assessments and reports, and for other purposes.
Introduced February 27, 2025 by Mark Edward Kelly · Last progress February 27, 2025
Provides new reporting, assessment, funding, and prosecutorial support for the High Intensity Drug Trafficking Areas (HIDTA) program focused on fentanyl and related substances. Requires annual HIDTA reports and assessments, expands HIDTA mission to prioritize interdiction of fentanyl, authorizes $333 million per year for FY2025–2030, and directs the Attorney General to make investigative and prosecutorial personnel (including temporary reassignment of Assistant U.S. Attorneys) available to HIDTAs with a formal reassignment request process to be established within 180 days of enactment.